Work

NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma

Year: 2020

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-019-00880-7

Authors: Ana M. Molina, Johannes C. van der Mijn, Paul Christos, John Wright, Charlene Thomas, Janice P. Dutcher, David M. Nanus, Scott T. Tagawa, Lorraine J. Gudas

Institutions: Weill Cornell Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, National Cancer Institute, Lady of Mercy Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

OpenAlex ID: W2997230917

FWCI: 1.354

Cites: 31

Cited by: 19

Related to: 10